NCT00879684 Safety And PK Study Of CVX-060 In Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00879554 A Safety And Pharmacokinetic Study With CVX-045 In Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00878735 The Effects of a Meditation Retreat on Healthy Volunteers and Cancer Patients: an fMRI Study Status COMPLETED Phase NA
NCT00876044 A Study to Evaluate the Effects of Aflibercept on QTc Interval in Cancer Patients Status COMPLETED Phase PHASE1
NCT00875264 Open-Label Study to Determine the Maximum Tolerated Oral Dose of the Kinase Inhibitor CEP-11981 in Patients With Advanced Cancer Status COMPLETED Phase PHASE1
NCT00872495 Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer Status RECRUITING Phase N/A
NCT00869895 A Dose-Finding Study of E7050 Administered Orally to Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00858377 A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00858364 Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy Status TERMINATED Phase PHASE3
NCT00852189 Study of EC0489 for the Treatment of Refractory or Metastatic Tumors Status COMPLETED Phase PHASE1
NCT00852111 Molecular-Genetic Correlates of Fatigue in Cancer Patients Receiving Localized External Beam Radiation Therapy Status COMPLETED Phase N/A
NCT00851448 Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Lung Cancer Patients Status TERMINATED Phase NA
NCT00850278 Assessment of [18F]FLT-PET Imaging for Diagnosis and Prognosis of Brain Tumors Status COMPLETED Phase NA
NCT00849550 Safety and Dosage Study of RAD001 (Everolimus) in Combination With Current Standard of Care to Treat Advanced Solid Tumors. Status COMPLETED Phase PHASE1
NCT00847522 Fluorescein for Lymphatic Mapping and Sentinel Lymph Node (SLN) Biopsy in Patients With Stage I and II Malignant Melanoma Status COMPLETED Phase PHASE1/PHASE2